The U.S. Department of Defense's Medical Supply Chain, through the Defense Logistics Agency (DLA), awarded a $28,617.60 fixed-price delivery order contract to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, which has an ultimate completion date of December 26, 2024, is for the procurement of specialized medical kits and devices, including surgical implants, arthroscopic instruments, and joint replacement technologies. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $471,048,172.66 and running from June 11, 2024, to September 1, 2029. This IDC allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic solutions through task orders. The current delivery order is not designated as a set-aside contract.
Generated 3/12/25, 9:56 AM